(Q45737034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

vaccinia virus

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Rik L. de Swart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

Theodorus H Van der Kwast

8 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

10

B Moss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

K J Stittelaar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Kuiken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G van Amerongen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

H W Vos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P van Schalkwijk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L S Wyatt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A D Osterhaus

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

3700-3709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized wit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Vaccination with Rev and Tat against AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

The age-dependent risk of postvaccination complications in vaccinees with smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Studies on poxvirus infections in irradiated animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Dosimetry for total body irradiation of rhesus monkeys with 300 kV X-rays

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Measles in a Dutch hospital introduced by an immuno-compromised infant from Indonesia infected with a new virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Viral replication and development of specific immunity in macaques after infection with different measles virus strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Cowpox: reservoir hosts and geographic range

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

Experimental measles. I. Pathogenesis in the normal and the immunized host.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900075-5

7 January 2021

10.1016/S0264-410X(01)00075-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395204%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference